Morgan Stanley Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $248

Morgan Stanley analyst Erin Wright maintains $Zoetis(ZTS.US)$ with a buy rating, and maintains the target price at $248.According to TipRanks data, the analyst has a success rate of 65.4% and a total

Futu NewsJun 28 20:31 · Ratings

Express News | Lifecome Biochemistry: signed a supply agreement with Solvay Belgium.

BreakingsJun 28 19:56

10 Health Care Stocks Whale Activity In Today's Session

BenzingaJun 27 01:35

Global Veterinary Pain Management Market Report 2024-2032, Featuring Assisi Animal Health, Bayer, Chanelle Pharma, Dechra Pharmaceuticals, Eli Lilly, Idexx Laboratories, Norbrook, Vetoquinol & Zoetis

Yahoo FinanceJun 24 22:35

Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Simply Wall StJun 23 20:52

Is Zoetis Stock Underperforming the Nasdaq?

BarchartJun 20 21:45